PTThe Paper Trail Project
PharmaceuticalsPaper Trail research

Merck & Co., Inc.

Merck & Co., Inc. is an organization in the Pharmaceuticals sector. Paper Trail tracks its public-money, lobbying, campaign-finance, corporate, and People relationships where supported by public records.

Federal spending

Total federal obligations

$2.3B

Obligations recorded from November 5, 2025 through November 4, 2026. Obligations are promises by the federal government to spend money, not necessarily cash already paid.

As of

November 4, 2026

Editorial context

Why It Is Included

Included as a major institution relevant to Paper Trail research; individual public-record connections appear only when sourced.

Direct public money received

Public Money Profile

Federal obligations are shown by award type and kept separate from tax incentives or workforce public-benefit research. These categories should not be added into a generic “subsidy” figure.

Federal contracts

$2.3B

Federal grants

$0

Direct payments

$0

Federal loans

$0

Other assistance

$0
Workforce public-benefit research

No published source-backed estimate linked unless shown elsewhere on this profile.

Tax incentives and subsidies

Not included without attributable official records.

Explore where federal money goes →

Connection explorer

Follow the Full Trail

Move from this organization to federal agencies, spending categories, reviewed corporate relationships, lobbying disclosures, its affiliated PAC, and political recipients.

Open Connection Explorer →

Federal data

Spending Over Time

Federal fiscal years

Prime-award transaction obligations attributed to this USAspending recipient. Negative totals can reflect deobligations or corrections.

$0
FY2017
$0
FY2018
$0
FY2019
$0
FY2020
$0
FY2021
$0
FY2022
$0
FY2023
$2.2B
FY2024
$2.9B
FY2025
$2.3B
FY2026
$283.1M
FY2027To date

The current fiscal year is partial and will change as USAspending publishes additional transactions.

Federal data

Who funds Merck & Co., Inc.?

The federal agencies and offices responsible for the organization’s recorded obligations.

ConnectedLast refreshed November 4, 2026

Prime-award transaction obligations from 2025-11-05 through 2026-11-04, grouped by top-tier awarding agency.

Federal data

What Federal Agencies Bought or Funded From Merck & Co., Inc.

USAspending classifies federal obligations using product and service codes for contracts and assistance-listing categories for grants and other assistance. These records describe federal awards to the organization—not the organization’s own operating expenses.

Products and services

SUPPORT- MANAGEMENT: OTHER

PSC R799

$1,627,6020.1% of total
IT AND TELECOM - NETWORK: SATELLITE AND RF COMMUNICATIONS PRODUCTS (HW, PERPETUAL LICENSE SOFTWARE)

PSC 7G22

$405,2270.0% of total
COMMERCIAL FISHING EQUIPMENT

PSC 2060

$122,6360.0% of total
MISCELLANEOUS ELECTRICAL AND ELECTRONIC COMPONENTS

PSC 5999

$81,5220.0% of total
LABORATORY EQUIPMENT AND SUPPLIES

PSC 6640

$81,0810.0% of total
IT AND TELECOM - NETWORK: ANALOG VOICE PRODUCTS (HARDWARE AND PERPETUAL LICENSE SOFTWARE)

PSC 7G20

$73,6690.0% of total
UNDERWATER SOUND EQUIPMENT

PSC 5845

$63,6140.0% of total
IT and Telecom - End User: Help Desk;Tier 1-2,Workspace,Print,Output,Productivity Tools (HW/Perp SW)

PSC 7E20

$25,9670.0% of total
INSTALLATION OF EQUIPMENT- SPECIAL INDUSTRY MACHINERY

PSC N036

$20,9140.0% of total
MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES

PSC 6515

$18,0000.0% of total
TIME MEASURING INSTRUMENTS

PSC 6645

$14,8300.0% of total
R&D- DEFENSE OTHER: OTHER (ADVANCED DEVELOPMENT)

PSC AD93

$00.0% of total
DRUGS AND BIOLOGICALS

PSC 6505

-$12,949-0.0% of total

Prime-award transaction obligations from 2025-11-05 through 2026-11-04. Categories can be broad and reflect federal coding, not Paper Trail editorial conclusions. View USAspending source ↗

Document library

Important Documents

Selected filings, reports, contracts, court records, and other documents useful for understanding this organization.

SEC Exhibit 21Company filing

Merck & Co., Inc. Exhibit 21 — Subsidiaries

Merck & Co., Inc. · Feb 24, 2026

Company-filed list of significant subsidiaries. The filing may omit subsidiaries that are not considered significant under SEC rules.

Documentation

Sources

For researchers

Cite this page

The Paper Trail Project. “Merck & Co., Inc..” Accessed November 7, 2026. https://www.papertrailproject.org/profiles/merck

Methodology

Record last updated 2026-11-04. Sources: USAspending.gov Recipient Profile. Verify consequential claims against the linked original records.